Thursday, November 19

    IBN

    AINewsWire Editorial Coverage: In today’s healthcare landscape, treating sickness after the fact is giving way to stopping it before it starts. U.S. health spending hit $5.3 trillion in 2024, and Medicare Advantage enrolls 35.2 million people today, equal to 55% of those eligible. For 2026,

    Bangladesh is currently grappling with a major measles outbreak that has seen more than 200,000 suspected cases of the disease recorded in the country, so far. Of those suspected cases, 22,000 have been confirmed by laboratory tests. These statistics cover

    Close to 1,000 workers at a Kansas City-area assembly plant have been sent home without a return date, caught in the fallout from Washington’s withdrawal of federal EV purchase support. General Motors had been targeting around 150,000 Chevrolet Bolts at the facility before

    Expanding renewables is increasingly viewed as Europe’s clearest path to reviving its industrial standing, as persistently high energy costs eat into the region’s manufacturing base. Electricity across the EU is still priced at more than twice pre-Ukraine war levels, and

    Chicago is preparing to make its commuter rail services cleaner with the introduction of battery-electric trains. Metra, the regional railroad serving the city and surrounding areas, has ordered eight new trainsets from Swiss manufacturer Stadler. The first trains are expected

    AINewsWire Editorial Coverage: Experimentation is giving way to commitment as Wall Street’s biggest firms embrace blockchain. BlackRock CEO Larry Fink expects “every stock, every bond” to eventually settle on a shared, tokenized ledger and Forbes reports that institutions are moving

    Elon Musk announced project Terafab, a project that will see him build a manufacturing plant that will produce AI chips on a massive scale. Terafab is currently backed by Tesla, xAI, and SpaceX. All are companies owned by the tech